Malondialdehyde and superoxide dismutase correlate with FEV1 in patients with COPD associated with wood smoke exposure and tobacco smoking

Inhalation Toxicology

Volumn 22, Issue 10, 2010, Pages 868-874

  Montaño, Martha ^a   Cisneros, José ^a   Ramírez Venegas, Alejandra ^a   Pedraza Chaverri, José ^b   Mercado, Daniel ^a   Ramos, Carlos ^a   Sansores, Raul H ^a  

^a Instituto Nacional de   (Mexico)

^b Ciudad Universitaria   (Mexico)

Author keywords

Biomass; COPD; Malondialdehyde; Oxidative stress; Superoxide dismutase; Tobacco smoking

Indexed keywords

GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TOBACCO SMOKE;

AGED; ARTICLE; BIOMASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MOLECULAR MECHANICS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SMOKE; SMOKING; WOOD;

AGED; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALONDIALDEHYDE; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKE; SMOKE INHALATION INJURY; SMOKING CESSATION; SUPEROXIDE DISMUTASE; TOBACCO; WOOD;

NICOTIANA TABACUM;

EID: 77955506279     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2010.491840     Document Type: Article

References (33)

1. Agacdiken A, Basyigit I, Ozden M, Yildiz F, Ural D, Maral H, Boyaci H, Ilgazli A, Komsuoglu B. 2004. The effects of antioxidants on exercise-induced lipid peroxidation in patients with COPD. Respirology 9:38-42.
2. Barregard L, Sallsten G, Andersson L, Almstrand AC, Gustafson P, Andersson M, Olin AC. 2008. Experimental exposure to wood smoke: effects on airway inflammation and oxidative stress. Occup Environ Med 65:319-324.
3. Boots AW, Haenen GR, Bast A. 2003. Oxidant metabolism in chronic obstructive pulmonary disease. Eur Respir J Suppl 46:14s-27s.
4. Brauer M, Bartlett K, Regalado-Pineda J, Perez-Padilla R. 1996. Assessment of particulate concentrations from domestic biomass combustion in rural Mexico. Environ Sci Tech 30:104-109.
5. Bruce N, Perez-Padilla R, Albalak R. 2002. The health effects of indoor air pollution exposure in developing countries. Geneva: World Health Organization: 9.
6. Carlberg I, Mannervik B. 1975. Purification and characterization of the flavoen-zyme glutathione reductase from rat liver. J Biol Chem 250:5475-5480.
7. Celli BR, MacNee W; ATS/ERS Task Force. 2004. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23:932-946.
8. Ceylan E, Kocyigit A, Gencer M, Aksoy N, Selek S. 2006. Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass. Respir Med 100:1270-1276.
9. Chung KF, Adcock IM. 2008. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 31:1334-1356.
10. Danielsen PH, Brauner EV, Barregard L, Sallsten G, Wallin M, Olinski R, Rozalski R, M0ller P, Loft S. 2008. Oxidatively damaged DNA and its repair after experimental exposure to wood smoke in healthy humans. Mutat Res 642:37-42.
11. Diaz JV, Koff J, Gotway MB, Nishimura S, Balmes JR. 2006. Case report: a case of wood-smoke-related pulmonary disease. Environ Health Perspect 114:759-762.
12. Drost EM, Skwarski KM, Sauleda J, Soler N, Roca J, Agusti A, MacNee W. 2005. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 60:293-300.
13. Gerard-Monnier D, Erdelmeier I, Regnard K, Moze-Henry N, Yadan JC, Chaudiere J. 1998. Reactions of 1-methyl-2-phenylindole with malondi-aldehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chem Res Toxicol 11:1176-1183.
14. Habig WH, Pabst MJ, Jakoby WB. 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130-7139.
15. Hankinson JL, Odencrantz JR, Fedan KB. 1999. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159:179-187.
16. Hanta I, Kocabas A, Canacankatan N, Kuleci S, Seydaoglu G. 2006. Oxidant-antioxidant balance in patients with COPD. Lung 184:51-55.
17. Isik B, Isik RS, Akyildiz L, Topgu F. 2005. Does biomass exposure affect serum MDA levels in women? Inhal Toxicol 17:695-697.
18. Joppa P, Petrasova D, Stancak B, Dorkova Z, Tkacova R. 2007. Oxidative stress in patients with COPD and pulmonary hypertension. Wien Klin Wochenschr 119:428-434.
19. Kluchova Z, Petrasova D, Joppa P, Dorkova Z, Tkacova R. 2007. The association between oxidative stress and obstructive lung impairment in patients with COPD. Physiol Res 56:51-56.
20. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S. 2006. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 27:397-412.
21. MacNee W. 2005. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2:50-60. (Pubitemid 40562963)
22. Menezes AM, Victora CG, Perez-Padilla R; PLATINO Team. 2004. The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol 4:15.
23. Morandi MT, Ward TJ; Risk Assessment Workgroup. 2010. Wood smoke risk assessment: defining the questions. Inhal Toxicol 22:94-98.
24. Naeher LP, Brauer M, Lipsett M, Zelikoff JT, Simpson CD, Koenig JQ, Smith KR. 2007. Woodsmoke health effects: a review. Inhal Toxicol 19:67-106.
25. Pedraza-Chaverrf J, Maldonado PD, Medina-Campos ON, Olivares-Corichi IM, Granados-Silvestre MA, Hernandez-Pando R, Ibarra-Rubio ME. 2000. Garlic ameliorates gentamicin nephrotoxicity: relation to antioxidant enzymes. Free Radic Biol Med 29:602-611.
26. Perez-Padilla R, Regalado J, Vedal S, Pare P, Chapela R, Sansores R, Selman M. 1996. Exposure to biomass smoke and chronic airway disease in Mexican women. A case-control study. Am J Respir Crit Care Med 154:701-706.
27. Perez-Padilla JR, Regalado-Pineda J, Vazquez-Garci'a JC. 2001. [Reproducibility of spirometry in Mexican workers and international reference values]. Salud Publica Mex 43:113-121.
28. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J; Global Initiative for Chronic Obstructive Lung Disease. 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532-555.
29. Rahman I. 2005a. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem Biophys 43:167-188.
30. Rahman I. 2005b. The role of oxidative stress in the pathogenesis of COPD: implications for therapy. Treat Respir Med 4:175-200.
31. Ramfrez-Venegas A, Sansores RH, Perez-Padilla R, Regalado J, Velazquez A, Sanchez C, Mayar ME. 2006. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med 173:393-397.
32. Ramlogan R. 1997. Environment and human health: a threat to all Environmental Management and Health. 8:51-66.
33. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators. 2008. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 359:15431554.